Adenocarcinoma — Trials

Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9,703 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,753
Recruiting: 1,520
Ph III recruiting: 168
Growth YoY: +6.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,319)

clinicaltrialsPublishedShowing 301–350 of 1,898 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06414733	HER-2 B Cell Peptide Vaccine	recruiting	Phase 1	42	Pravin T.P KaumayaOTHER	1	Aug 27, 2026	clinicaltrials
NCT06582017	Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma	recruiting	Phase 1	100	Nammi Therapeutics IncINDUSTRY	1	Aug 27, 2026	clinicaltrials
NCT06698458